Animal Intestinal Health Market

Animal Intestinal Health Market by Additive (Probiotics, Prebiotics, Phytogenics, Immunostimulants), Livestock (Poultry, Swine, Ruminant, Aquaculture), Form (Dry, Liquid), Source, Region - Global Forecast to 2027

Report Code: AGI 7802 Jul, 2022, by marketsandmarkets.com

[230 Pages Report] The animal intestinal health market is estimated at USD 3.7 billion in 2022 and is projected to grow to USD 5.4 billion in 2027, at a CAGR of 8.2% from 2022 to 2027. Key factors, such as an increase in the consumption of compound feed and feed additives, steady growth in the market for meat and meat products, and a shift toward natural growth promoters have contributed to the growth of the market. However, the high price of feed additives and the lack of awareness in developing countries pertaining to the right ratio for mixing these additives in compound feed products are expected to inhibit the market's growth during the forecast period.

Animal Intestinal Health Market

To know about the assumptions considered for the study, Request for Free Sample Report

Market Dynamics

Drivers: Increasing application of animal health ingredients in feed products to enhance livestock production and to ultimately improve animal protein quality

The rise in population, incomes, and urbanization are the key factors, which contribute to the unprecedented growth of the livestock sector. The result is increased consumption of food products, such as meat, eggs, and milk has increased. As demand is anticipated to rise, the increased production demand for healthy and nutritive poultry meat will propel the market growth. The increase in awareness among consumers about the health benefits associated with the consumption of animal protein, such as improved bone health, immunity, and reduction in protein deficiencies, is also one of the several factors due to which the demand for livestock products remains high.  The increase in demand for livestock products has led the stakeholders to use to feed addtitives such as probiotics, prebiotics and phytogenics to improve the animal health. For instance, digestive disorders such as stomach ulcers, swine dysentery, and transmissible gastroentrities among others are common in pigs. In order to avoid this orders and ensure effective animal health the feed additives such as phytogenics are being used in pigs.

Restraints: Introduction of stringent regulations pertaining to use of functional feed additives

International organizations, such as the US Food and Drug Administration (FDA), the US Center of Veterinary Medicine (CVM), the World Health Organization (WHO), the European Commission (EC), the European Food Safety Authority (EFSA), Australian Pesticides and Veterinary Medicines Authority (APVMA), Natural Health Product Directorate (NHPD), and the National Health Surveillance Agency (ANVISA) regulate the usage of various additives in feed products and issue stringent regulations for probiotic manufacturers. These organizations control the usage of different chemicals and ingredients used in feed processing. Regulatory initiatives pose challenges to various feed additives and add to the overall cost of developing the product. The major compound feed manufacturers are also required to submit patent and approval applications to launch new products in different countries, which adds to the cost of products. The approval processes are lengthy and usually consume more time.

Opportunities: Shift toward natural growth promoters (NGPs) due to increase in awareness about feed and food safety

Antimicrobial growth promoters (AGPs) are antibiotics that enhance the overall growth rate and production performance. The extended use of antibiotics results in the development of resistant bacteria and piling up antibiotic residue in the animals. With the increased awareness among consumers about the consequences of its presence in livestock products, a ban on the use of AGPs was proposed by the EU. This was primarily done to reduce the antibiotic resistance among pathogens in farm animals, thereby reducing the risk of its transmission to humans through food products. The subsequent shift to natural growth promoters, such as probiotics, prebiotics, phytogenics, and immunostimulants, contributes to the growth of the market

Challenges: Cost of active ingredients utilized in development of  phytogenic feed additives

Essential extracts from various spices and herbs are the most important raw materials used in the production of feed phytogenics. However, the prices of essential oils are high, which has hindered the growth of the feed phytogenics market. The average price of clove leaf oil in Madagascar was USD 10/kg in 2021. Moreover, adverse weather conditions and a rise in demand for spices are projected to lead to a rise in prices. Likewise, the export price for rosemary herb oil also increased in countries, such as Portugal, Spain, and Tunisia. The high cost of transportation also adds to the raw material cost, thereby driving the overall cost of products upwards.

The probiotics segment, by additive  dominates the market in terms of value.”

The probiotics segment is expected to account for the largest share in the market by 2027 due to the high adoption of additives among livestock breeders. A majority of the key players are focusing on offering probiotic products to improve the intestinal health of livestock species.

The poultry segment, by livestock held the largest in terms of value.”

The poultry segment is expected to account for the largest share during the forecast period, as most products cater to the requirements of poultry. Animal intestinal health products help to reduce incidences of diarrhea. They also stabilize intestinal microflora and enhance nutrient digestibility and digestive functions among poultry species. These products help poultry species gain weight and facilitate a higher feed conversion ratio. Since the population of poultry species is expected to grow, the demand for compound feed products for poultry species is expected to increase.

“Asia Pacific  is the fastest growing region.”

Asia Pacific is expected to account for the largest share during the forecast period. This is due to the increase in the demand for meat and meat products in countries such as China, India, and South Korea. The demand for poultry products is expected to be significantly high in the Asia Pacific region, which is expected to lead to a rise in demand for feed products for broilers and layers. With the westernization of diets in the emerging countries in the Asia Pacific region, the demand for beef and pork meat is expected to grow, which would also encourage the growth of the market studied

Animal Intestinal Health Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The key players in this market include Cargill, Incorporated (US), Koninklijke DSM N.V. (Netherlands), Archer Daniels Midland Company (US), DuPont de Nemours, Inc. (US), and Evonik Industries (Germany), Novozymes (Denmark), Nutreco (Netherlands), Chr. Hansen Holdings (Denmark), and Bluestar Adisseo Pvt Ltd. (China).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size estimation

2022–2027

Base year considered

2021

Forecast period considered

2022–2027

Units considered

Value (USD), Volume (Tons)

Segments covered

 By Additive, Livestock, Form, Function, Source, and Region 

Regions covered

North America, Asia Pacific, Europe, South America, and Rest of the World

Companies studied

  • Cargill, Incorporated (US)
  • Koninklijke DSM N.V. (Netherlands)
  • Archer Daniels Midland Company (US)
  • DuPont de Nemours, Inc. (US)
  • Evonik Industries (Germany)
  • Novozymes (Denmark)
  • Nutreco (Netherlands)
  • Chr. Hansen Holdings (Denmark)
  • Bluestar Adisseo Pvt Ltd. (China)

This research report categorizes the Animal intestinal health market based on Additive, Livestock, Form, Function, Source, and Region 

By Additive

  • Probiotics
  • Prebiotics
  • Phytogenics
  • Immunostimulants

By Livestock

  • Poultry
  • Ruminants
  • Swine
  • Aquaculture
  • Other Livestock

By Form

  • Dry
  • Liquid

By Function

  • Metabolism
  • Weight Gain
  • Nutrient Digestion
  • Disease Prevention
  • Bone and Joint Health

By Source

  • Microbial
  • Plant Based

By Region

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Rest of the World (RoW)

Recent Developments

  • In May 2021, CHR Hansen developed a new product using two strains of different species of Bacilli, Bacillus licheniformis and Bacillus subtilis, isolated from nature to support gut health in ruminants.
  • In November 2020, Evonik's Animal Nutrition business line launched Ecobiol Fizz, the first probiotic for chicken in effervescent tablet form. The product contains a microbial strain of the species Bacillus amyloliquefaciens, which is used to stabilize the intestinal microbiota of broilers and chickens reared for laying, particularly during stressful periods, such as breeding.
  • In September 2020, ADM Animal Nutrition launched Forage First GS for its high-quality nutritional support for gastrointestinal health. Its unique blend of ingredients supports a healthy gastric pH while protecting and strengthening the stomach lining of the equine.
  • In January 2020, Kemin Industries launched phytogenic feed additive adds to the comprehensive line-up of poultry gut health solutions from Kemin Animal Nutrition and Health, North America. It is a proprietary formulation of natural, gut-health-fortifying ingredients designed as a cost-effective solution for producers to minimize the impact of challenges, such as enteric diseases, on poultry performance.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 30)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 STUDY SCOPE
          FIGURE 1 MARKET SEGMENTATION
           1.3.1 REGIONS COVERED
    1.4 YEARS CONSIDERED
    1.5 CURRENCY CONSIDERED
          TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019-2021
    1.6 UNIT CONSIDERED
    1.7 STAKEHOLDERS
    1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA
          FIGURE 2 ANIMAL INTESTINAL HEALTH MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Breakdown of primary interviews
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
          FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY SIDE (1/2)
          FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY SIDE (2/2)
          FIGURE 6 MARKET SIZE ESTIMATION: DEMAND SIDE
           2.2.1 BOTTOM-UP APPROACH
                     FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
           2.2.2 TOP-DOWN APPROACH
                     FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
           2.4.1 ASSUMPTIONS
           2.4.2 LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 47)
    FIGURE 10 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027
    FIGURE 11 POULTRY SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027
    FIGURE 12 DRY FORM SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE BY 2022
    FIGURE 13 MICROBIAL SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SIZE BY 2027
    FIGURE 14 ASIA PACIFIC EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022

4 PREMIUM INSIGHTS (Page No. - 51)
    4.1 OPPORTUNITIES IN THE MARKET
          FIGURE 15 INCREASE IN DEMAND FOR FEED AND FEED ADDITIVES DRIVING GROWTH OF THE MARKET
    4.2 MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE
          FIGURE 16 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
    4.3 ASIA PACIFIC: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK AND KEY COUNTRIES
          FIGURE 17 CHINA AND POULTRY SEGMENT EXPECTED TO ACCOUNT FOR SIGNIFICANT MARKET SHARE IN ASIA PACIFIC MARKET IN 2022
    4.4 MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM AND REGION
          FIGURE 18 DRY SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE IN 2022
    4.5 MARKET FOR ANIMAL INTESTINAL HEALTH, BY MAJOR REGIONAL SUBMARKETS
          FIGURE 19 CHINA EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022

5 MARKET OVERVIEW (Page No. - 54)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 20 MARKET FOR ANIMAL INTESTINAL HEALTH: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increased production of compound feed
                                FIGURE 21 GLOBAL COMPOUND FEED PRODUCTION, 2012–2021 (MILLION METRIC TONS)
                                FIGURE 22 COMPOUND FEED PRODUCTION, BY TOP 7 COUNTRIES, 2016–2020 (MILLION METRIC TONS)
                    5.2.1.2 Rising demand for animal protein
                                TABLE 2 PER CAPITA CONSUMPTION OF LIVESTOCK PRODUCTS, BY REGION
                    5.2.1.3 Intestinal disorders among livestock
           5.2.2 RESTRAINTS
                    5.2.2.1 Stringent regulations for use of feed additives
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Innovations and technological advancements in feed industry
                    5.2.3.2 Increased awareness about feed and food safety
           5.2.4 CHALLENGES
                    5.2.4.1 High cost of feed additives
                               5.2.4.1.1 R&D costs associated with development of probiotics
                               5.2.4.1.2 High cost of active ingredients used in development of phytogenic feed additives

6 INDUSTRY TRENDS (Page No. - 61)
    6.1 INTRODUCTION
    6.2 TRENDS IMPACTING CUSTOMERS’ BUSINESS
           FIGURE 23 TRENDS IMPACTING ANIMAL INTESTINAL HEALTH MARKET
    6.3 VALUE CHAIN
           FIGURE 24 VALUE CHAIN ANALYSIS
    6.4 TRADE ANALYSIS
           FIGURE 25 EXPORT OF LIVESTOCK SPECIES, 2016–2021 (USD MILLION)
    6.5 TECHNOLOGY ANALYSIS
    6.6 PATENT ANALYSIS
           TABLE 3 KEY PATENTS PERTAINING TO ANIMAL INTESTINAL HEALTH, 2019–2022
    6.7 ECOSYSTEM MAP
           6.7.1 MARKET FOR ANIMAL INTESTINAL HEALTH: ECOSYSTEM MAP
                    FIGURE 26 FEED AND ANIMAL NUTRITION: ECOSYSTEM MAP
    6.8 PORTER’S FIVE FORCES ANALYSIS
          TABLE 4 PORTER’S FIVE FORCES ANALYSIS
           6.8.1 THREAT OF NEW ENTRANTS
           6.8.2 THREAT OF SUBSTITUTES
           6.8.3 BARGAINING POWER OF SUPPLIERS
           6.8.4 BARGAINING POWER OF BUYERS
           6.8.5 INTENSITY OF COMPETITIVE RIVALRY
    6.9 CASE STUDIES
           6.9.1 REGULATIONS ON ANTIBIOTICS LEADING TO A SHIFT TOWARD PROBIOTICS
    6.10 PRICING ANALYSIS
           6.10.1 MARKET FOR ANIMAL INTESTINAL HEALTH: AVERAGE SELLING PRICE TREND ANALYSIS
                      TABLE 5 AVERAGE SELLING PRICE, BY ADDITIVE, 2019–2027 (USD/KG)
    6.11 REGULATORY FRAMEWORK
           6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           6.11.2 CODEX ALIMENTARIUS COMMISSION (CAC)
                    6.11.2.1 North America
                    6.11.2.2 Europe
                    6.11.2.3 Asia Pacific
    6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
           6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
                      FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING ANIMAL INTESTINAL HEALTH PRODUCTS
                      TABLE 6 INFLUENCE OF STAKEHOLDERS ON TOP THREE PRODUCT TYPES
           6.12.2 BUYING CRITERIA
                      FIGURE 28 KEY BUYING CRITERIA FOR ADDITIVES
                      TABLE 7 KEY BUYING CRITERIA FOR ADDITIVES
    6.13 KEY CONFERENCES AND EVENTS, 2022–2023
           TABLE 8 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF CONFERENCES & EVENTS, BY REGION, 2022–2023

7 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE (Page No. - 79)
    7.1 INTRODUCTION
          FIGURE 29 PROBIOTICS SEGMENT EXPECTED TO DOMINATE THE MARKET BY 2027
          TABLE 9 MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE, 2019–2027 (USD MILLION)
          TABLE 10  MARKET, BY ADDITIVE, 2019–2027 (KT)
    7.2 PROBIOTICS
           7.2.1 PROBIOTIC MICROORGANISMS OFFER HEALTH BENEFITS
                    TABLE 11 PROBIOTICS: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 12 PROBIOTICS: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (KT)
    7.3 PREBIOTICS
           7.3.1 PREBIOTICS INDUCE GROWTH OF BENEFICIAL GUT BACTERIA
                    7.3.1.1 Oligosaccharides
                    7.3.1.2 Inulin
                    7.3.1.3 Other additives
                                TABLE 13 PREBIOTICS: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (USD MILLION)
                                TABLE 14 PREBIOTICS: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (KT)
    7.4 PHYTOGENICS
           7.4.1 PHYTOGENIC FEED ADDITIVES OFFER MORE THAN FLAVORING PROPERTIES
                    7.4.1.1 Essential oils
                    7.4.1.2 Flavonoids
                    7.4.1.3 Saponins
                    7.4.1.4 Oleoresins
                    7.4.1.5 Other additives
                                TABLE 15 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                                TABLE 16 PHYTOGENICS: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (KT)
    7.5 IMMUNOSTIMULANTS
           7.5.1 IMMUNOSTIMULANTS IMPROVE IMMUNITY AND REDUCE STRESS AND DISEASES IN AQUACULTURE
                    TABLE 17 IMMUNOSTIMULANTS: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 18 IMMUNOSTIMULANTS: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (KT)

8 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK (Page No. - 90)
    8.1 INTRODUCTION
          FIGURE 30 POULTRY SEGMENT EXPECTED TO DOMINATE THE MARKET DURING FORECAST PERIOD
          TABLE 19 MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
          TABLE 20 MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (KT)
    8.2 POULTRY
           8.2.1 FEED ADDITIVES ENHANCE POULTRY PERFORMANCE
                    TABLE 21 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION)
                    TABLE 22 POULTRY: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 23 POULTRY: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (KT)
                    8.2.1.1 Broilers
                    8.2.1.2 Layers
                    8.2.1.3 Turkey
                    8.2.1.4 Other poultry species
    8.3 SWINE
           8.3.1 RISE IN PORK TRADE AND CONCERNS OVER MEAT SAFETY
                    TABLE 24 PROBIOTIC MICROORGANISMS USED IN SWINE FEED
                    TABLE 25 SWINE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 26 SWINE: MARKET, BY REGION, 2019–2027 (KT)
    8.4 RUMINANTS
           8.4.1 FEED ADDITIVES BOOST PRODUCTION EFFICIENCY IN RUMINANTS
                    TABLE 27 RUMINANTS: MARKET FOR ANIMAL INTESTINAL HEALTH, BY TYPE, 2019–2027 (USD MILLION)
                    TABLE 28 RUMINANTS: MARKET, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 29 RUMINANTS: MARKET, BY REGION, 2019–2027 (KT)
                    8.4.1.1 Dairy cattle
                    8.4.1.2 Beef cattle
                    8.4.1.3 Calves
                    8.4.1.4 Other ruminant species
    8.5 AQUACULTURE
           8.5.1 FEED ADDITIVES IMPROVE FEED QUALITY AND ENHANCE AQUACULTURE PERFORMANCE
                    TABLE 30 AQUACULTURE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 31 AQUACULTURE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (KT)
    8.6 OTHER LIVESTOCK
           8.6.1 PHYTOGENIC-BASED ANIMAL INTESTINAL PRODUCTS IMPROVE DIGESTIBILITY IN PETS
                    TABLE 32 OTHER LIVESTOCK: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 33 OTHER LIVESTOCK: MARKET, BY REGION, 2019–2027 (KT)

9 ANIMAL INTESTINAL HEALTH MARKET, BY FORM (Page No. - 103)
    9.1 INTRODUCTION
           FIGURE 31 DRY SEGMENT EXPECTED TO DOMINATE THE MARKET DURING FORECAST PERIOD
           TABLE 34 MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (USD MILLION)
           TABLE 35 MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (KT)
    9.2 DRY
           9.2.1 EASE OF STORAGE AND TRANSPORTATION
                    TABLE 36 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 37 DRY FORM: MARKET, BY REGION, 2019–2027 (KT)
    9.3 LIQUID
           9.3.1 LIQUID SUPPLEMENTS PROVIDE UNIFORM TEXTURE TO FINAL PRODUCTS
                    TABLE 38 LIQUID FORM: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (USD MILLION)
                    TABLE 39 LIQUID FORM: MARKET, BY REGION, 2019–2027 (KT)

10 ANIMAL INTESTINAL HEALTH MARKET, BY FUNCTION (Page No. - 109)
     10.1 METABOLISM
             10.1.1 ADDITIVES IMPROVE SURVIVAL AND IMPLANTATION OF LIVE MICROBIAL DIETARY SUPPLEMENTS IN GI TRACT
     10.2 WEIGHT GAIN
             10.2.1 FEED ADDITIVES IMPROVE PRODUCTION AND PERFORMANCE OF RUMINANTS
     10.3 NUTRIENT DIGESTION
             10.3.1 FEED ADDITIVES IMPROVE DIGESTIBILITY OF NUTRIENTS
     10.4 DISEASE PREVENTION
             10.4.1 USE OF FEED ADDITIVES PREVENTS DISEASES IN ANIMALS AND IMPROVES HEALTH
     10.5 BONE AND JOINT HEALTH
             10.5.1 PREBIOTICS BETTER CALCIUM METABOLISM AND BONE HEALTH

11 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE (Page No. - 112)
     11.1 INTRODUCTION
             FIGURE 32 MICROBIAL SEGMENT EXPECTED TO DOMINATE THE MARKET DURING FORECAST PERIOD
             TABLE 40 MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 41 MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (KT)
     11.2 MICROBIAL
             11.2.1 PROBIOTICS PREPARED USING BACILLUS SUBTILIS AND STREPTOCOCCI IMPROVE EFFICIENCY IN POULTRY AND SWINE
                        TABLE 42 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION)
                        TABLE 43 MICROBIAL: MARKET, BY REGION, 2019–2027 (KT)
     11.3 PLANT-BASED
             11.3.1 PLANT-BASED SUBSTANCES IMPROVE NUTRIENT DIGESTIBILITY IN ANIMALS
                        TABLE 44 PLANT-BASED: MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (USD MILLION)
                        TABLE 45 PLANT-BASED: MARKET, BY REGION, 2019–2027 (KT)

12 ANIMAL INTESTINAL HEALTH MARKET, BY REGION (Page No. - 118)
     12.1 INTRODUCTION
             FIGURE 33 INDIA EXPECTED TO WITNESS HIGH GROWTH IN ANIMAL INTESTINAL HEALTH MARKET BETWEEN 2022 AND 2027
             TABLE 46 MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027 (USD MILLION)
             TABLE 47 MARKET FOR ANIMAL INTESTINAL HEALTH, BY REGION, 2019–2027(KT)
     12.2 NORTH AMERICA
             FIGURE 34 NORTH AMERICA: MARKET SNAPSHOT
             TABLE 48 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 49 NORTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE, 2019–2027 (USD MILLION)
             TABLE 50 NORTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE, 2019–2027 (KT)
             TABLE 51 NORTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             TABLE 52 NORTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (KT)
             TABLE 53 NORTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 54 NORTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (KT)
             TABLE 55 NORTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (USD MILLION)
             TABLE 56 NORTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (KT)
             12.2.1 US
                        12.2.1.1 Rise in consumption of poultry products
                                      TABLE 57 US: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.2.2 CANADA
                        12.2.2.1 Food safety concerns and government regulations
                                      TABLE 58 CANADA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.2.3 MEXICO
                        12.2.3.1 Rise in import of high-quality meat products
                                      TABLE 59 MEXICO: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
     12.3 EUROPE
             TABLE 60 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 61 EUROPE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE, 2019–2027 (USD MILLION)
             TABLE 62 EUROPE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE, 2019–2027 (KT)
             TABLE 63 EUROPE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             TABLE 64 EUROPE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (KT)
             TABLE 65 EUROPE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 66 EUROPE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (KT)
             TABLE 67 EUROPE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (USD MILLION)
             TABLE 68 EUROPE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (KT)
             12.3.1 SPAIN
                        12.3.1.1 Increased demand for meat and dairy products
                                      TABLE 69 SPAIN: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.3.2 GERMANY
                        12.3.2.1 Focus on offering high-quality meat products
                                      TABLE 70 GERMANY: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.3.3 FRANCE
                        12.3.3.1 Rising instances of disease outbreaks
                                      TABLE 71 FRANCE: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.3.4 ITALY
                        12.3.4.1 Need for alternative growth promoters encourage use of probiotics
                                      TABLE 72 ITALY: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.3.5 UK
                        12.3.5.1 Intensive farming results in high use of premium quality nutrients in animal intestinal health products
                                      TABLE 73 UK: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.3.6 REST OF EUROPE
                        12.3.6.1 Need for alternatives to antibiotic growth promoters encourage demand for phytogenics
                                      TABLE 74 REST OF EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
     12.4 ASIA PACIFIC
             FIGURE 35 ASIA PACIFIC: REGIONAL SNAPSHOT
             TABLE 75 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 76 ASIA PACIFIC: MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE, 2019–2027 (USD MILLION)
             TABLE 77 ASIA PACIFIC: MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE, 2019–2027 (KT)
             TABLE 78 ASIA PACIFIC: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             TABLE 79 ASIA PACIFIC: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (KT)
             TABLE 80 ASIA PACIFIC: MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (USD MILLION)
             TABLE 81 ASIA PACIFIC: MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (KT)
             TABLE 82 ASIA PACIFIC: MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 83 ASIA PACIFIC: MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (KT)
             12.4.1 CHINA
                        12.4.1.1 High consumption of meat
                                      TABLE 84 CHINA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.4.2 JAPAN
                        12.4.2.1 Preference for high-quality feed products
                                      TABLE 85 JAPAN: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.4.3 INDIA
                        12.4.3.1 Growing demand for high-quality poultry products
                                      TABLE 86 INDIA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.4.4 SOUTH KOREA
                        12.4.4.1 Increase in consumption of meat products
                                      TABLE 87 SOUTH KOREA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.4.5 AUSTRALIA & NEW ZEALAND
                        12.4.5.1 High consumption of meat products
                                      TABLE 88 AUSTRALIA & NEW ZEALAND: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.4.6 REST OF ASIA PACIFIC
                        12.4.6.1 Commercialization of livestock products
                                      TABLE 89 REST OF ASIA PACIFIC: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
     12.5 SOUTH AMERICA
             TABLE 90 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 91 SOUTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE, 2019–2027 (USD MILLION)
             TABLE 92 SOUTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE, 2019–2027 (KT)
             TABLE 93 SOUTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             TABLE 94 SOUTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (KT)
             TABLE 95 SOUTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 96 SOUTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (KT)
             TABLE 97 SOUTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (USD MILLION)
             TABLE 98 SOUTH AMERICA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (KT)
             12.5.1 BRAZIL
                        12.5.1.1 High demand for meat products due to high purchasing power of people
                                      TABLE 99 BRAZIL: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.5.2 ARGENTINA
                        12.5.2.1 Growth in animal husbandry sector
                                      TABLE 100 ARGENTINA: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.5.3 REST OF SOUTH AMERICA
                        12.5.3.1 Increased awareness among farmers about importance of feed supplements
                                      TABLE 101 REST OF SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)
     12.6 REST OF THE WORLD
             TABLE 102 REST OF THE WORLD: MARKET FOR ANIMAL INTESTINAL HEALTH, BY COUNTRY, 2019–2027 (USD MILLION)
             TABLE 103 REST OF THE WORLD: MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE, 2019–2027 (USD MILLION)
             TABLE 104 REST OF THE WORLD: MARKET FOR ANIMAL INTESTINAL HEALTH, BY ADDITIVE, 2019–2027 (KT)
             TABLE 105 REST OF THE WORLD: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             TABLE 106 REST OF THE WORLD: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (KT)
             TABLE 107 REST OF THE WORLD: MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (USD MILLION)
             TABLE 108 REST OF THE WORLD: MARKET FOR ANIMAL INTESTINAL HEALTH, BY SOURCE, 2019–2027 (KT)
             TABLE 109 REST OF THE WORLD: MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (USD MILLION)
             TABLE 110 REST OF THE WORLD: MARKET FOR ANIMAL INTESTINAL HEALTH, BY FORM, 2019–2027 (KT)
             12.6.1 MIDDLE EAST
                        12.6.1.1 High demand for animal-based protein products
                                      TABLE 111 MIDDLE EAST: MARKET FOR ANIMAL INTESTINAL HEALTH, BY LIVESTOCK, 2019–2027 (USD MILLION)
             12.6.2 AFRICA
                        12.6.2.1 Improvement in livestock health
                                      TABLE 112 AFRICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION)

13 COMPETITIVE LANDSCAPE (Page No. - 153)
     13.1 OVERVIEW
     13.2 MARKET EVALUATION FRAMEWORK
             FIGURE 36 MARKET EVALUATION FRAMEWORK, 2019–2022
     13.3 MARKET SHARE ANALYSIS
             TABLE 113 MARKET SHARE ANALYSIS, 2021
     13.4 REVENUE ANALYSIS FOR KEY COMPANIES, 2019-2021 (USD BILLION)
             FIGURE 37 REVENUE ANALYSIS OF KEY COMPANIES, 2019-2021 (USD BILLION)
     13.5 COMPANY EVALUATION QUADRANT
             13.5.1 STARS
             13.5.2 EMERGING LEADERS
             13.5.3 PERVASIVE PLAYERS
             13.5.4 PARTICIPANTS
                        FIGURE 38 MARKET FOR ANIMAL INTESTINAL HEALTH: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2021
     13.6 STARTUP EVALUATION QUADRANT
             13.6.1 PROGRESSIVE COMPANIES
             13.6.2 STARTING BLOCKS
             13.6.3 RESPONSIVE COMPANIES
             13.6.4 DYNAMIC COMPANIES
                        FIGURE 39 MARKET FOR ANIMAL INTESTINAL HEALTH: COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS, 2021
     13.7 PRODUCT FOOTPRINT (KEY PLAYERS)
             TABLE 114 COMPANY FOOTPRINT, BY LIVESTOCK
             TABLE 115 COMPANY FOOTPRINT, BY ADDITIVE
             TABLE 116 COMPANY FOOTPRINT, BY REGION
             TABLE 117 OVERALL COMPANY FOOTPRINT
             13.7.1 COMPETITIVE BENCHMARKING OF KEY PLAYERS
                        TABLE 118 MARKET FOR ANIMAL INTESTINAL HEALTH: DETAILED LIST OF KEY PLAYERS
             13.7.2 COMPETITIVE BENCHMARKING OF SMES/OTHER PLAYERS
                        TABLE 119 MARKET FOR ANIMAL INTESTINAL HEALTH: DETAILED LIST OF SMES/OTHER PLAYERS
     13.8 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS
             13.8.1 NEW PRODUCT LAUNCHES
                        TABLE 120 MARKET FOR ANIMAL INTESTINAL HEALTH: NEW PRODUCT LAUNCHES, 2019-2021
             13.8.2 OTHER DEVELOPMENTS
                        TABLE 121 MARKET FOR ANIMAL INTESTINAL HEALTH: OTHER DEVELOPMENTS, 2019-2020
             13.8.3 DEALS
                        TABLE 122 MARKET FOR ANIMAL INTESTINAL HEALTH: DEALS, 2020-2021

14 COMPANY PROFILES (Page No. - 168)
(Business overview, Products offered, Recent Developments, MNM view)*
     14.1 KEY PLAYERS
             14.1.1 ADM
                        TABLE 123 ADM: BUSINESS OVERVIEW
                        FIGURE 40 ADM: COMPANY SNAPSHOT
                        TABLE 124 ADM: PRODUCTS OFFERED
                        TABLE 125 ADM: OTHERS, 2021
                        TABLE 126 ADM: PRODUCT LAUNCHES, 2020
             14.1.2 KONINKLIJKE DSM N.V.
                        TABLE 127 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW
                        FIGURE 41 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
                        TABLE 128 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED
                        TABLE 129 KONINKLIJKE DSM N.V.: DEALS, 2020
             14.1.3 DUPONT NUTRITION & BIOSCIENCES (DANISCO ANIMAL NUTRITION)
                        TABLE 130 DUPONT NUTRITION & BIOSCIENCES: BUSINESS OVERVIEW
                        FIGURE 42 DUPONT NUTRITION & BIOSCIENCES: COMPANY SNAPSHOT
                        TABLE 131 DUPONT NUTRITION & BIOSCIENCES: PRODUCTS OFFERED
                        TABLE 132 DUPONT NUTRITION & BIOSCIENCES: DEALS, 2019-2021
                        TABLE 133 DUPONT NUTRITION & BIOSCIENCES: PRODUCT LAUNCHES, 2019
                        TABLE 134 DUPONT NUTRITION & BIOSCIENCES: OTHERS, 2020
             14.1.4 CARGILL INCORPORATED
                        TABLE 135 CARGILL INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 43 CARGILL INC.: COMPANY SNAPSHOT
                        TABLE 136 CARGILL INCORPORATED: PRODUCTS OFFERED
                        TABLE 137 CARGILL INCORPORATED: DEALS, 2020
                        TABLE 138 CARGILL INCORPORATED: OTHERS, 2022
             14.1.5 NOVOZYMES
                        TABLE 139 NOVOZYMES: BUSINESS OVERVIEW
                        FIGURE 44 NOVOZYMES: COMPANY SNAPSHOT
                        TABLE 140 NOVOZYMES: PRODUCTS OFFERED
                        TABLE 141 NOVOZYMES: DEALS, 2020
             14.1.6 KEMIN INDUSTRIES INC.
                        TABLE 142 KEMIN INDUSTRIES INC.: BUSINESS OVERVIEW
                        TABLE 143 KEMIN INDUSTRIES INC.: PRODUCTS OFFERED
                        TABLE 144 KEMIN INDUSTRIES: PRODUCT LAUNCHES, 2020
             14.1.7 NUTRECO
                        TABLE 145 NUTRECO: BUSINESS OVERVIEW
                        FIGURE 45 NUTRECO: COMPANY SNAPSHOT
                        TABLE 146 NUTRECO: PRODUCTS OFFERED
                        TABLE 147 NUTRECO: DEALS 2019-2020
             14.1.8 CHR. HANSEN HOLDING A/S
                        TABLE 148 CHR. HANSEN HOLDING A/S: BUSINESS OVERVIEW
                        FIGURE 46 CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT
                        TABLE 149 CHR. HANSEN HOLDING A/S: PRODUCTS OFFERED
                        TABLE 150 CHR. HANSEN HOLDING A/S: PRODUCT LAUNCHES, 2019-2021
                        TABLE 151 CHR. HANSEN HOLDING A/S: DEALS, 2020
             14.1.9 BLUESTAR ADISSEO CO. LTD.
                        TABLE 152 BLUESTAR ADISSEO: BUSINESS OVERVIEW
                        FIGURE 47 BLUESTAR ADISSEO CO. LTD.: COMPANY SNAPSHOT
                        TABLE 153 BLUESTAR ADISSEO CO. LTD.: PRODUCTS OFFERED
                        TABLE 154 BLUESTAR ADISSEO CO. LTD.: DEALS, 2020
             14.1.10 ALLTECH
                        TABLE 155 ALLTECH: BUSINESS OVERVIEW
                        TABLE 156 ALLTECH: PRODUCTS OFFERED
             14.1.11 EVONIK INDUSTRIES
                        TABLE 157 EVONIK INDUSTRIES: BUSINESS OVERVIEW
                        FIGURE 48 EVONIK INDUSTRIES: COMPANY SNAPSHOT
                        TABLE 158 EVONIK INDUSTRIES: PRODUCTS OFFERED
                        TABLE 159 EVONIK INDUSTRIES: PRODUCT LAUNCHES, 2020
             14.1.12 LALLEMAND INC.
                        TABLE 160 LALLEMAND INC.: BUSINESS OVERVIEW
                        TABLE 161 LALLEMAND INC.: PRODUCTS OFFERED
                        TABLE 162 LALLEMAND INC.: OTHER DEVELOPMENTS, 2019-2020
             14.1.13 BIORIGIN
                        TABLE 163 BIORIGIN: BUSINESS OVERVIEW
                        TABLE 164 BIORIGIN: PRODUCTS OFFERED
                        TABLE 165 BIORIGIN: DEALS, 2019
             14.1.14 LAND O’LAKES
                        TABLE 166 LAND O’LAKES: BUSINESS OVERVIEW
                        FIGURE 49 LAND O’LAKES: COMPANY SNAPSHOT
                        TABLE 167 LAND O’LAKES: PRODUCTS OFFERED
                        TABLE 168 LAND O’LAKES: OTHERS, 2019
                        TABLE 169 LAND O’LAKES: DEALS, 2019
             14.1.15 LESAFFRE
                        TABLE 170 LESAFFRE: BUSINESS OVERVIEW
                        TABLE 171 LESAFFRE: PRODUCTS OFFERED
                        TABLE 172 LESAFFRE: OTHER DEVELOPMENTS, 2019-2020
                        TABLE 173 LESAFFRE: PRODUCT LAUNCHES, 2019
             14.1.16 CALPIS CO LTD
                         TABLE 174 CALPIS CO LTD.: BUSINESS OVERVIEW
             14.1.17 AB VISTA
             14.1.18 PURE CULTURES
             14.1.19 DR. ECKEL ANIMAL NUTRITION GMBH & CO. KG
             14.1.20 UNIQUE BIOTECH

*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

15 ADJACENT AND RELATED MARKETS (Page No. - 218)
     15.1 INTRODUCTION
            TABLE 175 ADJACENT MARKETS TO ANIMAL INTESTINAL HEALTH
     15.2 LIMITATIONS
     15.3 PHYTOGENIC FEED ADDITIVES MARKET
             15.3.1 MARKET DEFINITION
             15.3.2 MARKET OVERVIEW
                        TABLE 176 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2016–2019 (USD MILLION)
                        TABLE 177 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2020–2025 (USD MILLION)
     15.4 PROBIOTICS IN ANIMAL FEED MARKET
             15.4.1 MARKET DEFINITION
                        TABLE 178 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2017–2020 (USD MILLION)
                        TABLE 179 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2021–2026 (USD MILLION)

16 APPENDIX (Page No. - 222)
     16.1 DISCUSSION GUIDE
     16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     16.3 AVAILABLE CUSTOMIZATION
     16.4 RELATED REPORTS
     16.5 AUTHOR DETAILS

This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of Animal intestinal health market. In-depth interviews were conducted with various primary respondents—such as key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants—to obtain and verify critical qualitative and quantitative information as well as to assess prospects.

Secondary Research

In the secondary research process, various sources such as annual reports, press releases & investor presentations of companies, white papers, food journals, certified publications, articles from recognized authors, gold & silver standard websites, directories, and databases, were referred to identify and collect information.

Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, and market classification and segmentation as per the industry trends to the bottom-most level, regional markets, and key developments from both market- and technology oriented perspectives.

Primary Research

In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information. The primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the market.

Animal Intestinal Health Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the total size of market. These methods were also used extensively to estimate the size of the various subsegments in the market. The research methodology used to estimate the market size includes the following:

The key players in the industry and market have been identified through extensive secondary research.

All macroeconomic and microeconomic factors affecting the growth of the Animal Intestinal Health were considered while estimating the market size.

All possible parameters that affect the market covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain final quantitative and qualitative data.

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using the top-down and bottom-up approaches.

Report Objectives

  • To define, segment, and project the global market for Animal intestinal health on the basis of Additive, Livestock, Form, Function, Source, and Region 
  • To provide detailed information regarding the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and their contribution to the total market
  • To analyze the opportunities in the market for stakeholders and provide a competitive landscape of the market leaders
  • To project the size of the market and its submarkets, in terms of value and volume, with respect to the regions (along with the key countries)
  • To strategically profile the key players and comprehensively analyze their market position and core competencies
  • To analyze the competitive developments such as joint ventures, mergers & acquisitions, new product developments, and research & developments in the Animal intestinal health  market.

Target Audience

  • Animal intestinal health raw material suppliers
  • Animal intestinal health manufacturers
  • Government and research organizations
  • Associations, regulatory bodies, and other industry-related bodies:
  • United States Department of Agriculture (USDA)
  • Association of American Feed Control Officials (AAFCO)
  • The Compound Feed Manufacturers Association (CLFMA)
  • The EU Association of Specialty Feed Ingredients and their Mixtures (FEFANA)
  • International Feed Industry Federation (IFIF)
  • Food and Agriculture Organisation (FAO)
  • Animal Feed Manufacturers Association (AFMA)

Available Customizations

With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.

The following customization options are available for the report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolio of each company

Geographic Analysis

  • With the given market data, MarketsandMarkets offers customizations according to the company-specific scientific needs.
  • Rest of Europe includes Belgium, Norway, Sweden, and other EU & non-EU countries.
  • Rest of Asia Pacific includes Indonesia, the Philippines, Malaysia, Singapore, and Vietnam.
  • Rest of South America includes Chile, Colombia, Paraguay, and other South American countries.

Company Information

  • Detailed analyses and profiling of additional market players (up to five)
Animal Intestinal Health Market Size,  Share & Growth Report
Report Code
AGI 7802
Published ON
Jul, 2022
Choose License Type
BUY NOW
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status